Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test

EBioMedicine. 2020 Dec:62:103143. doi: 10.1016/j.ebiom.2020.103143. Epub 2020 Nov 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Capsid Proteins / immunology*
  • Disease Susceptibility
  • Early Detection of Cancer / methods
  • Early Detection of Cancer / standards
  • Human papillomavirus 16 / immunology*
  • Humans
  • Mass Screening / methods
  • Mass Screening / standards*
  • Neoplasms / diagnosis
  • Neoplasms / epidemiology*
  • Neoplasms / etiology*
  • Oncogene Proteins, Viral / immunology*
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / virology
  • Public Health Surveillance
  • Seroepidemiologic Studies

Substances

  • Capsid Proteins
  • Oncogene Proteins, Viral
  • L1 protein, Human papillomavirus type 16